09.08.25 -- Unlocking The Pharmacological Potential Of Antibodies

Explore how the processing speed of cell separation methods impacts product quality, process efficiency, and overall economics.

Compare random and semi-targeted integration strategies for stable cell line development, highlighting their impact on expression consistency, scalability, and regulatory considerations.

To meet the growing demand for mAbs and their variants, it is important to leverage opportunities for optimization as well as work with suppliers that have the resources to help your workflow thrive.

Learn more about the cutting-edge technologies driving the shift to microbial expression and how the right outsourcing partner can help you leverage the benefits of these innovative therapeutics.

Allogeneic cell therapies offer incredible promise, but scaling up PSC manufacturing presents unique challenges. Explore these hurdles along with solutions for consistent, high-quality production.

For efficient, scalable, and cost-effective cell and exosome production, 3D cell culture is the answer. Learn how this advanced approach surpasses 2D limitations, unlocking new potential for therapies.

A single-site "landing pad" CHO cell line simplifies the creation of mammalian display libraries, enabling consistent, single-copy integration of target sequences for biologic drug discovery.

Streamline lentiviral vector analytics with our direct RT-dPCR method. Achieve precise, reproducible results to accelerate safe, effective gene therapies with enhanced quality control.

Cryopreservation enables cell therapy by storing cells long-term. A DMSO-free formula preserves cell viability and health, minimizing toxicities linked with traditional cryoprotectants.